x FOREWORD To address these important issues, the Task Force on Hypertension in Pregnancy, composed of 17 experts in the fields of obstetrics, maternal–fetal medicine, hypertension, internal medicine, nephrology, anesthesiology, physiology, and patient advocacy, was created and charged with three tasks: 1) summarize the current state of knowledge about preeclampsia and other hypertensive disorders in pregnancy by reviewing and grading the quality of the extant world literature; 2) translate this information into practice guidelines for health care providers who treat obstetric patients affected by these disorders; and 3) identify and prioritize the most compelling areas of laboratory and clinical research to bridge gaps in our current knowledge. Members of the task force met three times over 9 months during 2011 and 2012 at the College headquarters in Washington, DC. They spent countless additional hours writing and deliberating to achieve consensus on the practice recommendations that follow in the Executive Summary. I am deeply grateful to each member of the Task Force on Hypertension in Pregnancy for their hard work and dedication to this important endeavor. References 1. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hyper- tension, United States, 1987–2004. Am J Hypertens 2008;21:521–6. [PubMed] ^ 2. World Health Organization. The world health report: 2005: make every mother and child count. Geneva: WHO; 2005. Available at: http://www.who.int/whr/2005/whr 2005_en.pdf. Retrieved March 20, 2013. ^ 3. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992;99:547–53. [PubMed] ^In addition, I would like to give special thanks to Dr. James M. Roberts of the University of Pittsburgh’s Magee-Womens Research Institute for his superb leadership of the task force and to Nancy O’Reilly, Senior Director of Practice Bulletins, and Dr. Gerald F. Joseph Jr, Vice President of Practice Activities, at the College for their support throughout the process. Efforts are now underway to achieve global consensus on best practice guidelines for the diagnosis and management of preeclampsia and other hypertensive disorders of pregnancy. It is my fervent hope that the work of the Task Force on Hypertension in Pregnancy serves as a springboard to these efforts and ultimately translates into improved obstetric care for patients with preeclampsia and other hypertensive disorders of pregnancy in this country and throughout the world. James N. Martin Jr, MD Immediate Past President The American College of Obstetricians and Gynecologists 2012–2013 The American Congress of Obstetricians and Gynecologists 2012–2013 4. Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991–2003. Am J Obstet Gynecol 2008;199:133.e1–8. [PubMed] [Full Text] ^ 5. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009;113:1299–306. [PubMed] [Obstetrics & Gynecology] ^ 6. van Dillen J, Mesman JA, Zwart JJ, Bloemenkamp KW, van Roosmalen J. Introducing maternal morbidity audit in the Netherlands. BJOG2010;117:416–21. [PubMed] [Full Text] ^